U.S. Health Care REITs Stock News

Wondering if Bath & Body Works at around US$19.20 is a bargain or a value trap? This article focuses squarely on what the current price may be implying about the stock. The stock has risen 4.7% over the last week and 6.0% over the last month, yet year to date it shows a 7.4% decline and the 1 year return stands at 34.8% lower. This pattern may catch the eye of value focused investors. Recent coverage around specialty retail and consumer discretionary spending has put companies like Bath &...

Some investors may be considering whether Douglas Dynamics at around US$45.42 is still offering value after a strong run, or whether much of the opportunity is already reflected in the current share price. The stock has recorded returns of 2.8% over 7 days, 8.1% over 30 days, 37.7% year to date and 83.6% over 1 year. This puts recent price action front and center for anyone weighing the balance between potential and risk. Recent coverage has highlighted Douglas Dynamics as a Machinery sector...

InnovAge Holding (INNV) has posted a mixed Q3 2026 result, with revenue at US$251.9 million and a basic EPS loss of US$0.22 alongside net income of US$29.5 million in the red. The company’s revenue increased from US$218.1 million in Q3 2025 to US$251.9 million in Q3 2026, while quarterly EPS moved from a loss of US$0.08 to a loss of US$0.22 over the same period. This sets up a narrative that now focuses on how quickly margins can be repaired to align with the growth in the top line. See our...

Fabrinet (FN) has just posted Q3 2026 results with revenue of US$1.2 billion, basic EPS of US$3.49 and net income of US$125.2 million, against a backdrop of 29% reported earnings growth over the last year and a trailing 12 month earnings growth rate of 19.2% per year over the past five years. The company has seen revenue move from US$871.8 million in Q3 2025 through US$909.7 million in Q4 2025 and US$978.1 million in Q1 2026 to US$1.2 billion in Q3 2026. Over the same span, basic EPS has gone...

Vontier (NYSE:VNT) highlighted its multi energy fleet technology strategy at ACT Expo 2026. The company presented an integrated platform that combines traditional and new energy refueling, EV management, diagnostics, payment security, and telematics. The event showcased new solutions aimed at supporting fleet decarbonization and digital transformation. For investors tracking the fleet and mobility sector, Vontier sits at the intersection of hardware, software, and services for...

Phibro Animal Health Corporation has reported its third-quarter 2026 results, with sales of US$383.54 million and net income of US$24.02 million, alongside the launch of its Sustainable Solutions Platform and Verratain™ low‑carbon feed products in partnership with VAXA Technologies. The combination of stronger earnings and a companywide push into emissions‑focused feed ingredients suggests Phibro is tying profitability more closely to sustainability trends across animal protein and petfood...

Coty (COTY) Q3 2026: Earnings Snapshot Coty (COTY) has just posted its Q3 2026 numbers, with revenue of US$1.3 billion, basic EPS of a US$0.47 loss, and a net income loss of US$411.4 million setting the tone for the quarter. Over recent periods the company has seen quarterly revenue move from US$1.3 billion in Q3 2025 to US$1.3 billion in Q3 2026, with basic EPS unchanged at a US$0.47 loss. Trailing twelve month EPS stand at a US$0.62 loss and net income at a US$545.8 million loss, which...

Earnings and convertible notes set the stage for Ocugen stock Ocugen (OCGN) is back in focus after reporting first quarter 2026 results and closing a US$103.5 million convertible note offering, a combination that puts both its cash needs and capital structure in the spotlight. See our latest analysis for Ocugen. The recent 1 day share price return of 2.35% decline and 7 day share price return of 13.39% decline suggest some short term profit taking after the earnings release and convertible...

Oncolytics Biotech reported new durability and response data for its pelareorep therapy in RAS-mutant MSS metastatic colorectal cancer. The pelareorep-based regimen outperformed historical benchmarks in second-line treatment, with longer median duration of response and higher objective response rates. The company has initiated enrollment in a Phase 2 randomized study and is in active discussions with the FDA on a potential accelerated approval pathway. For investors watching NasdaqCM:ONCY,...

Aurora Innovation (NasdaqGS:AUR) has signed its first commercial contract for fully driverless long haul trucking with McLane Company. The partnership will use autonomous trucks to run driverless routes in Texas for a major national distributor. Aurora plans to scale to 200 fully driverless trucks and broaden its US route network by year end. Aurora Innovation focuses on autonomous driving technology, with trucking as a key commercial application. The McLane agreement moves the company from...

BJ's Restaurants (BJRI) opened 2026 with Q1 revenue of US$358.1 million and basic EPS of US$0.43, alongside trailing 12 month revenue of about US$1.4b and EPS of US$2.05 that reflect reported earnings growth of 98.1% year over year and a 5 year annualized earnings growth rate of 66.7%. Over the last few quarters the company has seen revenue move from US$347.9 million and EPS of US$0.59 in Q1 2025 to US$355.4 million and EPS of US$0.60 in Q4 2025, before landing at the current Q1 2026 levels...

Loma Negra Compañía Industrial Argentina Sociedad Anónima (NYSE:LOMA) opened 2026 with Q1 results that put revenue at about ARS 218.7b and basic EPS at ARS 351.37, setting a clear marker for how the year is starting to shape up. Over the past few quarters, the company has seen revenue move from about ARS 279.4b in Q4 2024 to ARS 172.9b in Q1 2025 and then to ARS 270.6b in Q4 2025. Basic EPS shifted from ARS 360.89 to ARS 195.07 and then to ARS 64.39, so this latest print lands against a...

Kennametal (KMT) Q3 2026 earnings snapshot Kennametal (KMT) has reported Q3 2026 revenue of US$592.6 million and basic EPS of US$0.76 on net income of US$58.2 million, alongside 14.6% earnings growth and a net profit margin that improved to 5.4% over the past year. The company’s revenue increased from US$482.1 million in Q2 2025 to US$529.5 million in Q2 2026 and then to US$592.6 million in the latest quarter. Over the same period, quarterly EPS rose from US$0.23 to US$0.44 and then to...

EyePoint Pharmaceuticals (EYPT) opened 2026 with Q1 revenue of US$0.7 million, a basic EPS loss of US$0.99 per share and a net income loss of US$84.8 million, setting a clear tone for how profitability is tracking into the new year. The company has seen quarterly revenue move from US$24.5 million in Q1 2025 to US$0.7 million in Q1 2026, while quarterly basic EPS shifted from a loss of US$0.65 to a loss of US$0.99. The latest print keeps the focus squarely on how much cash the business is...

NACCO Industries (NC) opened 2026 with Q1 revenue of US$62.8 million and basic EPS of US$1.18, setting a clear marker against a share price of US$50.74. Over recent quarters, the company has reported revenue of US$65.6 million in Q1 2025, US$70.4 million in Q4 2024 and US$62.8 million in Q1 2026, while quarterly EPS moved from US$0.67 in Q1 2025 to US$1.04 in Q4 2024 and US$1.18 in Q1 2026. This sequence gives investors a clearer view of how revenue and earnings are tracking through the...

S&P Global Ratings upgraded Las Vegas Sands (NYSE:LVS) and its Macau unit to BBB from BBB-. The upgrade follows what S&P described as a disciplined financial policy, limited new development plans, and a recovery in Macau operations. Soon after the upgrade, Las Vegas Sands issued US$1b in new senior notes intended to refinance existing debt on improved terms. S&P also pointed to the potential for higher shareholder rewards, including the possibility of further share buybacks. For you as an...

SelectQuote (SLQT) just reported a busy Q2 2026, with total revenue of US$537.1 million and net income of US$51.2 million, which translated to basic EPS of US$0.27. The company’s quarterly revenue had previously stood at US$481.1 million with EPS of US$0.31 in Q2 2025, followed by a mix of losses and profits in subsequent periods, before arriving at the current quarter’s figures. For you as an investor, this latest report highlights a balance between improving profitability on one hand and...

If you are wondering whether Willis Lease Finance at around US$229 per share still offers value, you are not alone in asking what the current price really reflects. The stock has recently posted returns of 19.6% over 7 days, 30.2% over 30 days, 70.8% year to date and 72.3% over 1 year, with very large gains over 3 and 5 years. Recent headlines have focused on Willis Lease Finance within the capital goods and aircraft leasing space, highlighting how investors are paying closer attention to...

Phathom Pharmaceuticals (PHAT) recently reported first quarter results showing a net loss of US$30.37 million, alongside reaffirmed 2026 guidance that includes an operating profitability target beginning in the third quarter. See our latest analysis for Phathom Pharmaceuticals. The stock’s recent 12.62% 1 month share price return, alongside a 7.56% 7 day gain, contrasts with a 19.35% year to date share price decline. At the same time, the 1 year total shareholder return above 400% highlights...

If you are wondering whether Floor & Decor Holdings at around US$51 a share is attractively priced or a potential value trap, the starting point is understanding how the current market price lines up against different measures of value. The stock has recently moved 7.0% over the last week and 3.3% over the last month, while the year to date return sits at a 19.0% decline and the 1 year return at a 30.5% decline, which may catch the eye of investors weighing up risk and recovery...

This article examines whether Cohen & Steers at US$69.54 is offering fair value and breaks down what the current price may be indicating about the stock. The share price is up 0.9% over the last week and 11.0% over the past month. Year to date it is up 9.4%, while the 1 year return stands at a 6.4% decline, set against a 3 year return of 42.2% and a 5 year return of 17.1%. Recent headlines have focused on Cohen & Steers in the context of the wider Capital Markets sector, with attention on...

Investors may be wondering whether Oppenheimer Holdings at around US$99 a share still offers value, or if most of the opportunity has already been priced in. The stock has been volatile recently, with an 11.3% pullback over the last 7 days alongside a 9.3% gain over 30 days, and returns of 36.8% year to date and 69.4% over the past year. Recent headlines around capital markets activity and trading conditions have kept investor attention on brokers and financial services stocks, including...

If you are wondering whether Weatherford International at around US$108.61 is still offering value after its run, this breakdown will help you see what the current price really reflects. The stock has seen a 14.0% gain over the last 30 days and a 34.3% return year to date, while the 1 year return sits at 151.7% despite a 1.5% decline over the past week. Recent news around Weatherford International has focused on its position within the broader energy services sector and how investors are...

XCF Global (SAFX) has drawn fresh attention after a series of updates, including a Q1 2026 operational briefing, a business combination agreement, a forbearance deal with lender Twain, and a sector conference appearance. See our latest analysis for XCF Global. Recent updates around the Reno facility restart, the business combination agreement, and the Twain forbearance deal have coincided with a sharp shift in sentiment, with a 90 day share price return of 166.1% but a 3 year total...